Neoadjuvant chemotherapy has been used to extend surgical options by downstaging tumor in both locally advanced and operable breast cancer. An early imaging assessment of tumor response to neoadjuvant chemotherapy is critical for timely tailoring personalized treatment strategies. In this study, we investigate whether the changes in the parameters derived from a non-Gaussian diffusion model – continuous-time random-walk (CTRW) model – are predictive of pathologic response in women undergoing neoadjuvant chemotherapy. Our results demonstrate the high predictive performance of the combined changes in CTRW parameters from pre-treatment levels as early as the second cycle of chemotherapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords